Literature DB >> 2839836

Direct evidence for functional self-protein/Ia-molecule complexes in vivo.

R G Lorenz1, P M Allen.   

Abstract

Through the development of a panel of murine hybridomas reactive to murine hemoglobin, we have been able to study the processing and presentation of self antigens by antigen-presenting cells. Our results demonstrate that peritoneal macrophages in vivo can process and potentially present the self-antigen hemoglobin. We have extended this finding to show that, directly after removal from the mouse, antigen-presenting cells from a variety of tissues stimulate our hemoglobin-specific hybridomas without any manipulation or addition of exogenous antigen. This constitutes direct functional proof that in a nondisease state self proteins are processed constitutively and can be presented in a fashion similar to that in which foreign antigens are presented. Our demonstration that antigen-presenting cells can process and potentially present self as well as foreign molecules implies that self-tolerance occurs at the level of the T cell. This constitutive processing and presentation of self antigens has potentially far-reaching implications in self-tolerance, autoimmunity, and alloreactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839836      PMCID: PMC281720          DOI: 10.1073/pnas.85.14.5220

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules.

Authors:  B Bogen; B Malissen; W Haas
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

2.  Peptides related to the antigenic determinant block T cell recognition of the native protein as processed by antigen-presenting cells.

Authors:  E K Lakey; E Margoliash; G Flouret; S K Pierce
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

3.  HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.

Authors:  C Clayberger; P Parham; J Rothbard; D S Ludwig; G K Schoolnik; A M Krensky
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

4.  Antigenic competition at the level of peptide-Ia binding.

Authors:  B P Babbitt; G Matsueda; E Haber; E R Unanue; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

6.  Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas.

Authors:  P M Allen; E R Unanue
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

Review 7.  Cellular mechanisms of immunologic tolerance.

Authors:  G J Nossal
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

8.  The handling of Listeria monocytogenes by macrophages: the search for an immunogenic molecule in antigen presentation.

Authors:  P M Allen; D I Beller; J Braun; E R Unanue
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes.

Authors:  H Wekerle; M Schwab; C Linington; R Meyermann
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  31 in total

1.  The effect of neonatal tolerance to bovine gamma globulin (BGG) on BGG-reactive CD4+ T lymphocytes.

Authors:  S S Burtles; D C Hooper
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 2.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.

Authors:  C V Harding; E R Unanue
Journal:  Cell Regul       Date:  1990-06

3.  Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen.

Authors:  D E Speiser; T Zürcher; H Ramseier; H Hengartner; P Staeheli; O Haller; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 4.  Self determinant selection and acquisition of the autoimmune T cell repertoire.

Authors:  G Benichou; R C Tam; P I Orr; M R Garovoy; E V Fedoseyeva
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4+ T cells.

Authors:  D T Hagerty; B D Evavold; P M Allen
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 6.  Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus.

Authors:  C J Hackett; L C Eisenlohr
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 7.  Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Authors:  H Fujiwara; T Hamaoka
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

8.  Self-pMHCII complexes are variably expressed in the thymus and periphery independent of mRNA expression but dependent on the activation state of the APCs.

Authors:  Stephanie N Rodriguez; Meizi Jiang; Hideaki Bujo; Paul M Allen
Journal:  Mol Immunol       Date:  2014-10-22       Impact factor: 4.407

Review 9.  Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Paul M Allen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis.

Authors:  S C Smith; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.